CYRANO THERAPEUTICS
Cyrano Therapeutics is developing an intranasal product designed to restore function in patients with a chronic loss of taste and smell. The company's product (CYR-001) repurposes an approved molecule (Theophylline) for this new indication and has been tested with success in a pilot study. Eight out of the 10 patients treated had significant improvement in taste and smell within 2 weeks with no reported side effects. The primary treatment provider will be the Otolaryngologist (Ear, Nose, and Throat specialist) and credible clinical investigators in this specialty have been identified and have expressed interest in participating in the clinical program. Cyrano Therapeutics was founded in 2014 and is headquartered in Washington, DC, USA.
CYRANO THERAPEUTICS
Social Links:
Industry:
Health Care Medical Medical Device Therapeutics
Founded:
2014-01-01
Address:
Washington, District Of Columbia, United States
Country:
United States
Website Url:
http://www.cyranotherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
12.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default WordPress Apache Wordpress Plugins Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Current Advisors List
Current Employees Featured
Founder
Investors List
Remiges Ventures
Remiges Ventures investment in Series A - Cyrano Therapeutics
Lumira Ventures
Lumira Ventures investment in Series A - Cyrano Therapeutics
Official Site Inspections
http://www.cyranotherapeutics.com
- Host name: 244.0.153.160.host.secureserver.net
- IP address: 160.153.0.244
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
